Identification of the novel HLA-B allele, B*51:01:101, by next-generation sequencing.

Humans Alleles HLA-B Antigens / genetics High-Throughput Nucleotide Sequencing
HLA-B*51:01:101 HLA-B NGS new HLA allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
Aug 2023
Historique:
revised: 14 04 2023
received: 10 04 2023
accepted: 17 04 2023
medline: 17 7 2023
pubmed: 2 5 2023
entrez: 2 5 2023
Statut: ppublish

Résumé

The novel HLA-B*51:01:101 allele was characterized using next generation sequencing technology.

Identifiants

DOI: 10.1111/tan.15080 PMID: 37128644
pubmed: 37128644
doi: 10.1111/tan.15080
doi:

Substances chimiques

HLA-B Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-232

Subventions

Organisme : Charity fund "National Bone Marrow Donors Registry named after Vasya Perevoshchikov"
Organisme : Kazan Federal University Strategic Academic Leadership Program (PRIORITY-2030)

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Barker DJ, Maccari G, Georgiou X, et al. IPD-IMGT/HLA Database. Nucleic Acids Res. 2023;51:D1053-D1060.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Liliya Aksenova (L)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Anastasiia Ananeva (A)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.
ORCID: 0000-0002-8069-7244

Anna V Andryushkina (AV)

National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation.

Elena I Shagimardanova (EI)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.
ORCID: 0000-0003-2339-261X

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Identification of the novel HLA-B allele,...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Identification of the novel HLA-B allele,...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-B › Identification of the novel HLA-B allele,...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Identification of the novel HLA-B allele,...